While neither our genetic nor our mRNA studies revealed positive findings for CCL5, the three MCP chemokines CCL2 (MCP-1), CCL7 (MCP-3) and CCL8 (MCP-2) showed altered regional expressions in MS brains. The gene discussed is CCL2; the disease is myeloid sarcoma.